Delivery Order SPE2DB22D2206-SPE2DB25FHA22
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$68K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product. The fixed-price delivery order, valued at $24,949.38, has a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $2,727.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a delivery order for 4,564,325,417 units of the drug Nitazoxanide 500 mg tablets, with a completion date of April 19, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,769.75 firm fixed-price delivery order is for the supply of NITAZOXANIDE 500 MG TABLET 6S, a medical product, with a performance period extending through May 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $37,071.03, is for the delivery of 4,567,908,563 units of the drug Nitazoxanide 500 mg tablets. The contract has a completion date of April 15, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This federal contract award, valued at $39,110.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567118252 nitazoxanide 500 mg tablets, a pharmaceutical product, with a period of performance through February 3, 2025. This is a firm-fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of nitazoxanide 500 mg tablets over a 2-year period ending in May 2024. The firm fixed-price contract has a ceiling value of $19,431.44 and was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) within the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,903.00, is for the delivery of Nitazoxanide 500 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The contract is for the delivery of 500 mg nitazoxanide tablets with a completion date of February 21, 2024 and a potential value of $5,055.24. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order, valued at $10,836.15, is for the...